Dr. Evan Cole Lewis MD, FRCPC, CSCN EEG Diplomate

Dr. Evan Cole Lewis is a Neurologist and Clinical Neurophysiologist with expertise in pediatric neurology and epilepsy. He is the founder & medical director of the Neurology Centre of Toronto (NCT) and VP Psychedelic Neurology Clinical Services at Numinus – a Canadian company focused on psychedelic research and therapeutics. He is an Assistant Professor with the Department of Pediatrics at the Hospital for Sick Children and the University of Toronto. Education, Training & Work Dr. Lewis attained his MD from the University of Ottawa and trained as a Pediatric Neurologist at the Children’s Hospital of Eastern Ontario (CHEO).  He completed fellowships in both clinical neurophysiology and epilepsy at Nicklaus Children’s Hospital (formerly known as Miami Children’s Hospital) and the Hospital for Sick Children. Dr. Lewis held staff positions at SickKids and Holland Bloorview Kids Rehabilitation Hospital between 2016 and 2018. Work in Medical Cannabis Dr. Lewis has significant clinical experience with medical cannabis in adults and children and is a member of the Canadian Consortium for the Investigation of Cannabinoids (CCIC), the Cannabinoid Research Initiative of Saskatchewan (CRIS) and the Canadian Childhood Cannabinoid Clinical Trials (C4T) group. He is a qualified investigator and site lead for a clinical trial in cannabis treatment of chronic headache in adolescents that is set to begin in the winter of 2022. Dr. Lewis is the Chief Medical Adviser for the Jamaican Medical Cannabis Corporation. He is a member of the Expert Committee of the Medical Cannabis Clinicians Society (MCCS) in the United Kingdom and sits on the Advisory Councils for Cannabis Patient Advocacy & Support Services (CPASS) and MedCan. He has spoken extensively on cannabis in neurologic disorders nationally and internationally. Positions & Research Dr. Lewis is a Fellow of the Royal College of Physicians of Canada and was the Tariff Chair of the Neurology Section for the Ontario Medical Association from 2017 - 2019. He sits on the Editorial Board for the Journal of Child Neurology’s Resident/Fellow Section and is an ad-hoc reviewer for the Canadian Journal of Neurological Sciences and Paediatrics & Child Health.  His research and special interests include psychedelic neurology, cannabinoids in the treatment of epilepsy & other neurological conditions and the delivery of novel virtual care models in neurology. Dr. Lewis is an advocate for the use of virtual medicine to reach the underserved areas of Ontario, Canada. Publications: Link to Publications: https://goo.gl/yLhvN1